Michael S Wertheim Selected Research

Michael S Wertheim Research Topics

3	Uveitis 06/2009 - 07/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013 - 05/2012
2	Inflammation (Inflammations) 07/2005 - 07/2005
1	Neoplasms (Cancer) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Edema (Dropsy) 11/2013
1	Posterior Uveitis 12/2008
1	Embolism (Embolus) 07/2005
1	Heart Failure 07/2005
1	Vitreous Hemorrhage 07/2005

2	Infliximab (Remicade)FDA Link 06/2009 - 07/2005
1	parsaclisibIBA 01/2019
1	itacitinibIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Ifosfamide FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Janus Kinase 1IBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	onartuzumabIBA 11/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2013
1	ErbB Receptors (EGF Receptor)IBA 11/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013
1	Tyrosine Kinase InhibitorsIBA 05/2012
1	XL647IBA 05/2012
1	Retinaldehyde (Retinal)IBA 12/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2005
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2005

3	Therapeutics 06/2009 - 07/2005
1	Drug Therapy (Chemotherapy) 01/2019